Application 208890
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RITONAVIR | RITONAVIR | TABLET;ORAL | 100MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65162-061 | Ritonavir | Ritonavir | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-061 | Ritonavir | Ritonavir | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-061 | Ritonavir | Ritonavir | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-061 | Ritonavir | Ritonavir | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-061 | Ritonavir | Ritonavir | Amneal Pharmaceuticals LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 55245 | ORIG | 2018-08-20 |